G1 Therapeutics ROA 2016-2024 | GTHX
Current and historical return on assets (ROA) values for G1 Therapeutics (GTHX) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2024-06-30 | $-0.04B | $0.10B | -38.60% |
| 2024-03-31 | $-0.03B | $0.10B | -23.76% |
| 2023-12-31 | $-0.05B | $0.12B | -33.98% |
| 2023-09-30 | $-0.07B | $0.13B | -45.01% |
| 2023-06-30 | $-0.08B | $0.15B | -46.92% |
| 2023-03-31 | $-0.13B | $0.16B | -71.59% |
| 2022-12-31 | $-0.15B | $0.19B | -77.37% |
| 2022-09-30 | $-0.15B | $0.17B | -74.09% |
| 2022-06-30 | $-0.17B | $0.19B | -75.39% |
| 2022-03-31 | $-0.17B | $0.22B | -68.55% |
| 2021-12-31 | $-0.15B | $0.25B | -54.29% |
| 2021-09-30 | $-0.13B | $0.24B | -49.91% |
| 2021-06-30 | $-0.10B | $0.28B | -38.02% |
| 2021-03-31 | $-0.09B | $0.31B | -35.81% |
| 2020-12-31 | $-0.10B | $0.23B | -39.68% |
| 2020-09-30 | $-0.11B | $0.26B | -41.37% |
| 2020-06-30 | $-0.13B | $0.25B | -46.36% |
| 2020-03-31 | $-0.13B | $0.26B | -43.32% |
| 2019-12-31 | $-0.12B | $0.29B | -37.95% |
| 2019-09-30 | $-0.11B | $0.32B | -32.36% |
| 2019-06-30 | $-0.10B | $0.33B | -27.35% |
| 2019-03-31 | $-0.09B | $0.35B | -27.24% |
| 2018-12-31 | $-0.09B | $0.37B | -29.54% |
| 2018-09-30 | $-0.08B | $0.39B | -35.25% |
| 2018-06-30 | $-0.07B | $0.19B | -48.37% |
| 2018-03-31 | $-0.07B | $0.20B | -49.01% |
| 2017-12-31 | $-0.07B | $0.11B | -72.42% |
| 2017-06-30 | $-0.04B | $0.13B | -119.40% |
| 2017-03-31 | $-0.03B | $0.00B | inf% |
